Rigel Pharmaceuticals (RIGL) News Today $20.12 +0.42 (+2.13%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RIGL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period 17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP bought a new position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 17,123 shares of the biotechnolMay 20 at 3:14 AM | marketbeat.comEnsign Peak Advisors Inc Makes New $1.44 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Ensign Peak Advisors Inc acquired a new position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 85,878 shares of the biotechnology company's stock, valued at approximatelMay 19 at 4:14 AM | marketbeat.comJacobs Levy Equity Management Inc. Raises Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Jacobs Levy Equity Management Inc. boosted its holdings in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 202,089 shares of tMay 17, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLCOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 27.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owneMay 16, 2025 | marketbeat.comUpgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) ForecastsMay 11, 2025 | finance.yahoo.comB. Riley Expects Reduced Earnings for Rigel PharmaceuticalsRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) - Investment analysts at B. Riley cut their Q2 2025 EPS estimates for Rigel Pharmaceuticals in a report issued on Tuesday, May 6th. B. Riley analyst K. Patel now forecasts that the biotechnology company will post earnings per share of $0.14May 11, 2025 | marketbeat.comHC Wainwright Has Optimistic Outlook of RIGL Q2 EarningsRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) - Investment analysts at HC Wainwright upped their Q2 2025 earnings per share estimates for shares of Rigel Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 7th. HC Wainwright analyst J. Pantginis now exMay 11, 2025 | marketbeat.comHC Wainwright Issues Positive Outlook for RIGL EarningsMay 11, 2025 | americanbankingnews.comB. Riley Research Analysts Cut Earnings Estimates for RIGLMay 11, 2025 | americanbankingnews.comAnalysts Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Target Price at $36.40May 11, 2025 | americanbankingnews.comB. Riley Equities Analysts Lift Earnings Estimates for RIGLRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) - Investment analysts at B. Riley increased their FY2025 earnings estimates for shares of Rigel Pharmaceuticals in a report released on Tuesday, May 6th. B. Riley analyst K. Patel now expects that the biotechnology company will earn $0.93 peMay 10, 2025 | marketbeat.comEquities Analysts Offer Predictions for RIGL Q3 EarningsRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) - Equities research analysts at HC Wainwright upped their Q3 2025 earnings per share (EPS) estimates for Rigel Pharmaceuticals in a research note issued on Wednesday, May 7th. HC Wainwright analyst J. Pantginis now expects that the biotechnoMay 10, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of "Hold" by AnalystsRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) has received an average rating of "Hold" from the five brokerages that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and two have issued a buy rating on the compMay 10, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting NextMay 9, 2025 | uk.finance.yahoo.comRigel Pharmaceuticals (NASDAQ:RIGL) Price Target Raised to $23.00Cantor Fitzgerald lifted their price objective on Rigel Pharmaceuticals from $20.00 to $23.00 and gave the stock a "neutral" rating in a report on Wednesday.May 9, 2025 | marketbeat.comRigel Pharmaceuticals, Inc.: Rigel Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 8, 2025 | finanznachrichten.deRigel Pharmaceuticals: Q1 Earnings Showcase Growing MomentumMay 7, 2025 | seekingalpha.comRigel Pharmaceuticals (RIGL) Price Target Raised by Cantor Fitzgerald | RIGL Stock NewsMay 7, 2025 | gurufocus.comRigel pharmaceuticals targets $200M-$210M revenue in 2025 with strong Q1 performanceMay 7, 2025 | msn.comRigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Report Preview: What To ExpectMay 7, 2025 | finance.yahoo.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Voya Investment Management LLCVoya Investment Management LLC lowered its stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 54.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 108,587 shares of the biotechnology company's stock afteMay 7, 2025 | marketbeat.comRigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...May 7, 2025 | gurufocus.comRigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comRigel Pharmaceuticals Inc Surpasses Q1 2025 Estimates with $0.64 EPS and $53.3 Million RevenueMay 6, 2025 | gurufocus.comRigel Pharmaceuticals (RIGL) Surpasses Q1 Revenue Expectations | RIGL Stock NewsMay 6, 2025 | gurufocus.comRigel Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | prnewswire.com5RIGL : A Preview Of Rigel Pharmaceuticals's EarningsMay 6, 2025 | benzinga.comRigel Pharmaceuticals (RIGL) to Release Earnings on TuesdayRigel Pharmaceuticals (NASDAQ:RIGL) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-rigel-pharmaceuticals-inc-stock/)May 1, 2025 | marketbeat.comRigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business UpdateApril 29, 2025 | prnewswire.comJump Financial LLC Increases Stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Jump Financial LLC raised its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 96.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 30,035 shares of the biotechnology company's stock after buying an addApril 27, 2025 | marketbeat.comWalleye Capital LLC Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Walleye Capital LLC bought a new stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 21,621 shares of the biotechnology company's sApril 27, 2025 | marketbeat.comJPMorgan Chase & Co. Acquires 154,254 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)JPMorgan Chase & Co. grew its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 587.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 180,492 shares of the biotechnology company'sApril 23, 2025 | marketbeat.comRenaissance Technologies LLC Grows Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Renaissance Technologies LLC lifted its stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 111.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 299,709 shares of the biotechApril 22, 2025 | marketbeat.com85,423 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Bought by Zacks Investment ManagementZacks Investment Management purchased a new stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 85,423 shares of the biotechnology companyApril 21, 2025 | marketbeat.comVanguard Group Inc. Grows Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Vanguard Group Inc. grew its stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,012,931 shares of the biotechnoApril 19, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Holdings Decreased by Kennedy Capital Management LLCKennedy Capital Management LLC decreased its holdings in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 85.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,418 shares of the bioteApril 18, 2025 | marketbeat.comWellington Management Group LLP Buys Shares of 34,983 Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Wellington Management Group LLP purchased a new position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 34,983 shares of the biotechnology company's stock, valueApril 16, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Hold" from BrokeragesShares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) have earned a consensus recommendation of "Hold" from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and two have givApril 15, 2025 | marketbeat.comExodusPoint Capital Management LP Invests $260,000 in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)ExodusPoint Capital Management LP bought a new stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,483 shares of the biotechnology companApril 15, 2025 | marketbeat.comTrexquant Investment LP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Trexquant Investment LP acquired a new stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 44,171 shares of the biotechnology company's stock, valued at approApril 14, 2025 | marketbeat.comNorges Bank Invests $2.18 Million in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Norges Bank acquired a new stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 129,506 shares of the biotechnologyApril 14, 2025 | marketbeat.comRigel Pharmaceuticals: 3-Drug Company Reaches ProfitabilityApril 4, 2025 | seekingalpha.comRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)April 4, 2025 | gurufocus.comRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)April 4, 2025 | prnewswire.comSegall Bryant & Hamill LLC Purchases Shares of 36,259 Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Segall Bryant & Hamill LLC acquired a new position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 36,259 shares of the biotechnologyMarch 30, 2025 | marketbeat.comRigel Pharmaceuticals resolves patent litigation related to TavalisseMarch 28, 2025 | markets.businessinsider.comRigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent LitigationMarch 27, 2025 | prnewswire.comHillsdale Investment Management Inc. Has $2.86 Million Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Hillsdale Investment Management Inc. increased its holdings in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 814.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 170,100 shares of the biotechnoloMarch 24, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of "Hold" by BrokeragesRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) has been given a consensus recommendation of "Hold" by the five brokerages that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. ThMarch 19, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 42.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 139,128 shares oMarch 19, 2025 | marketbeat.com Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address RIGL Media Mentions By Week RIGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RIGL News Sentiment▼1.540.65▲Average Medical News Sentiment RIGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RIGL Articles This Week▼44▲RIGL Articles Average Week Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Celldex Therapeutics News MannKind News Novavax News Dynavax Technologies News Innoviva News OPKO Health News Geron News Regulus Therapeutics News Zenas Biopharma News Verastem News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RIGL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RIGL Stock Free RIGL Stock Alerts